- ‘I Am Alive’ app gains popularity in terror-ravaged Lebanon
- Gun giveaways gain popularity among Republican candidates
- S.C. hospital worker slapped with $525 federal fine for refilling $0.89 soda
- Teen from ‘Jihad Jane’ plot becomes youngest ever to serve time on U.S. terror charges
- Iranian woman forgives son’s killer at the gallows
- Nebraska principal sorry for ‘don’t tattle’ flier
- Illinois readies to spend $100M for Obama museum in Chicago
- John Edwards back in court — this time as a lawyer for Va. boy’s malpractice case
- Covered California reports more than 200K in overtime Obamacare sign-ups
- Thanks, Chuck: Hagel says U.S. sending Ukraine sleeping mats, helmets
Latest Amgen Items
A national long-term care pharmacy accused of accepting kickbacks from a drug manufacturer has agreed to a settlement of more than $4 million, with New York getting a share of the money.
The Supreme Court appeared divided Monday in two cases in which businesses are trying to make it harder for customers or investors to band together to sue them.
George Rathmann, who as founding CEO took Amgen Inc. from a small company with an unclear mission in a strange new field and helped turn it into the world's largest biotech drugmaker, has died at age 84.
Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
Biotech drugmaker Amgen says federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in patients with advanced cancer.
Biotechnology company Amgen Inc. on Monday posted an 11 percent drop in third-quarter profit on flat sales and higher operating costs, although the drugmaker still beat expectations.
The Medicare payment system for dialysis drugs encourages doctors to prescribe aggressive dosing levels that can lead to heart attacks and strokes in kidney patients, lawmakers said yesterday.